Huge Spread in Patient Copays for HCV Drugs
From nothing to more than $25,000
by John Gever
Managing Editor, MedPageToday
Managing Editor, MedPageToday
October 17, 2016
LAS VEGAS -- One center's experience with arranging curative drug therapy for hepatitis C virus (HCV) infections showed an enormous variation in the out-of-pocket charges patients were asked to bear, researchers said here.
Among 300 patients treated in the Hofstra Northwell Physician Partners system in Manhasset, N.Y., with insurance from 31 private and public payors, copays ranged from zero to nearly $27,000, said Northwell's Susan Lee, PharmD at the American College of Gastroenterology annual meeting.
Continue reading @ MedPageToday
ACG
American College of Gastroenterology
Meeting Coverage
Among 300 patients treated in the Hofstra Northwell Physician Partners system in Manhasset, N.Y., with insurance from 31 private and public payors, copays ranged from zero to nearly $27,000, said Northwell's Susan Lee, PharmD at the American College of Gastroenterology annual meeting.
Continue reading @ MedPageToday
ACG
American College of Gastroenterology
Meeting Coverage
No comments:
Post a Comment